sexual assault a report on human immunodeficiency virus postexposure prophylaxis性侵犯报告曝光后预防人类免疫缺陷病毒.pdfVIP

  • 1
  • 0
  • 约4.68万字
  • 约 7页
  • 2017-09-01 发布于上海
  • 举报

sexual assault a report on human immunodeficiency virus postexposure prophylaxis性侵犯报告曝光后预防人类免疫缺陷病毒.pdf

sexual assault a report on human immunodeficiency virus postexposure prophylaxis性侵犯报告曝光后预防人类免疫缺陷病毒

Hindawi Publishing Corporation Obstetrics and Gynecology International Volume 2010, Article ID 196963, 6 pages doi:10.1155/2010/196963 Research Article Sexual Assault: A Report on Human Immunodeficiency Virus Postexposure Prophylaxis William F. Griffith,1 Gary E. Ackerman,1 Cindy L. Zoellner,2 and Jeanne S. Sheffield1 1 Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390-9032, USA 2 Pharmacy Department, Parkland Health and Hospital System, Dallas, TX 75232, USA Correspondence should be addressed to William F. Griffith, william.griffith@ Received 18 March 2010; Accepted 22 June 2010 Academic Editor: Howard D. Homesley Copyright © 2010 William F. Griffith et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The objective of this report is to describe an urban county hospital human immunodeficiency virus (HIV) infection prevention protocol offering prophylactic combination antiretroviral medications to female victims of sexual assault. A retrospective chart review was conducted from June, 2007 through June, 2008 of 151 women who were prescribed antiretroviral prophylaxis by protocol. All women receiving HIV prophylaxis initially screened HIV seronegative. Of the 58 women who reported taking any HIV prophylaxis, 36 (62%) were HIV screened at 12 and/or 24 weeks and none had HIV seroconverted. Although the initiation of an HIV post exposure prophylaxis protocol for sexual assault in a county hospital population is feasible, patient follow-up for counseling and HIV serostatus evaluation is an identified barrier 1. Int

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档